Lymphatic filariasis: Govt launches free medicine distribution

Image
Press Trust of India New Delhi
Last Updated : Jan 14 2015 | 10:30 PM IST
The government has launched a public health campaign to provide more than 400 million people with free medication that could protect them from lymphatic filariasis, also called elephantiasis, that can cause disability and disfigurement among those infected.
The disease has high prevalence and serious complications, but its prevention is very easy. The Health Ministry, however, has faced enormous difficulties in combating the disease.
Many people are complacent when it comes to prevention, in part because of apathy toward the disease and the length of time it takes to manifest itself (8 to 10 years). In addition, many people fail to consume their medicine even with the government's door-to-door efforts to deliver free, preventive doses and educational messaging in endemic regions.
"India has made great strides over the last decade to eliminate lymphatic filariasis in endemic states and we are now on the verge of reaching elimination targets nationally. However, the last mile of the journey is often the most difficult," said CK Mishra, Additional Secretary and Mission Director of the National Health Mission at Ministry of Health.
"We are employing a wide range of new communications tactics and partnership that will help us encourage all people at risk from this disease to consume free dose of medicine during our annual mass drug administrations," he said.
The Ministry has partnered with the Global Network for Neglected Tropical Diseases (Global Network), an initiative of the Sabin Vaccine Institute, to lead the development of a branded public service advertising campaign (PSA) called 'Hathipaon Mukt Bharat'(Filariasis Free India) in close coordination with the Ministry's National Vector Borne Disease Control Programme.
This campaign supports the government's massive effort to deliver preventive medication to high-risk communities within 17 states, including four states in particular that comprise nearly two-thirds of the lymphatic filariasis burden in India which are Uttar Pradesh, Jharkhand, Bihar and West Bengal.
"Nearly 500 million people in India are at risk of contracting lymphatic filariasis. India's success in eliminating this devastating disease will bolster global efforts to eliminate lymphatic filariasis and other neglected tropical diseases in other endemic countries," said Dr Neeraj Mistry, Managing Director of the Global Network and a campaign consultant for the Ministry.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 14 2015 | 10:30 PM IST

Next Story